Fig. 2.
Changes in metacarpal bone dimensions over 24 months (estimated mean ± 95% confidence interval). Solid line growth hormone treatment group, dashed line untreated group. a Bone width (centimetres), b endosteal diameter (centimetres), c cortical thickness (centimetres), d CSMI (×1,000). p values indicate treatment difference from baseline to end of trial. p < 0.0001